About Biolog
Biolog is a Healthcare company based in Hayward (United States) founded in 1984. Cell-based phenotyping technologies and assays are provided for microbial analysis. Biolog has raised $33.62 million across 6 funding rounds from investors including HHS, Broadoak Capital Partners and Research Corporation Technologies. The company has 27 employees. Biolog has completed 3 acquisitions, including Anaerobesystems, MIDI Labs and Microbial Identification. Its website biolog.com draws about 12 thousand monthly visits. Biolog offers products and services including Odin ID Station, EcoPlate, Anaerobic Chambers, and GEN III Test Panel. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Cell Biology. Its legal entity is BIOLOG, INC. Its competitors include 10X Genomics, Mission Bio and Cellares; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 1984 and headquartered in Hayward, United States, Biolog focuses on biotechnology solutions for microbial identification and analysis. Technologies such as the Microbial ID System are utilized to identify over 2,900 species of aerobic and anaerobic bacteria, yeasts, and fungi. Chromogenic media like Rainbow Agar, EcoPlates for community profiling, and Phenotype MicroArrays for parallel phenotype assessment are offered. Research services based on Phenotype MicroArrays are also conducted.
- Headquarters Hayward, United States
- Employees 27
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website biolog.com
- Social LinkedIn X Facebook
- Legal Name Biolog, Inc.
- Total Equity Funding$33.62M (USD)
in 6 rounds
- Latest Funding Round$16.12M (USD), Series A
Feb 2025
- InvestorsHHS
& 3 more
- Employee Count27
- Investments & AcquisitionsAnaerobesystems
& 2 more
Products & Services of Biolog
Biolog offers a comprehensive portfolio of products and services, including Odin ID Station, EcoPlate, Anaerobic Chambers, and GEN III Test Panel.
System for microbial identification and characterization
Tool for monitoring environmental microbial communities
Provides oxygen-free environments for microbial culture
Identifies aerobic bacteria for research applications
Funding Insights of Biolog
Biolog has successfully raised a total of $33.62M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $16.12 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $33.62M
- Total Rounds 6
- Last Round Series A — $16.12M
- First Round $1.4M
(Sep 2007)
- Investors Count 4
All 6 funding rounds of Biolog with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2025 | $16.12M | Series A | – | – | – |
| Jan 2023 | $17.5M | Series A | – | Broadoak Capital Partners | |
| Aug 2018 | Unspecified | – | – | ||
| Sep 2009 | $1.4M | Grant | – | – | |
| Sep 2009 | $1.4M | Grant | – | – | |
| Sep 2007 | $1.4M | Grant | – | – |
4 investors in total: 4 institutional.
Investors in Biolog
Biolog has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Broadoak Capital Partners and Research Corporation Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Research Corporation Technologies is engaged in licensing biomedical technologies. | rctech.com | Tucson, United States | ||
| redfundcapital.com | ||||
Investment banking services are offered in the United States. | 2006 | broadoak.com | Bethesda, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Biolog
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Biolog
28 people are tracked at Biolog (10 in leadership, 18 in team); the tracked headcount is 27.
| Name | Role | Group |
|---|---|---|
Tim Mullane | President & CEO | Leadership |
John Proctor, Ph.D. | Chief Commercial Officer (CCO) | Leadership |
Gianfranco (John) Battista | Vice President Of Sales - EMEA & ROW | Leadership |
Kristine Bissell | Vice President Sales | Leadership |
Sandy A. | Senior Vice President of Laboratory Services | Leadership |
Barry Bochner | Chief Science Advisor | Leadership |
Любовь Коломбет | Head of Division for Cell Technology | Leadership |
Joe Keegan | Director | Leadership |
Dina Finan | Director Of Product Management | Leadership |
Xueyang Feng | Senior Director of Biology and Applications | Leadership |
Trung Tran | Assistant Controller | Team |
Kasia Proctor | Marketing and Business Development | Team |
jim hass | manager | Team |
Mostafa Subhi | Biologist | Team |
DENİZ DOĞRU | Biologist | Team |
Lawrence Wiater | Senior Scientist & Group Leader | Team |
Andre Chouankam | Distribution Sales Manager - EMEA & ROW | Team |
Daniela Kuenzel | Project Manager | Team |
Paola Loreto | Biology Specialist | Team |
Tammy Greer | Quality Assurance Manager | Team |
8 more people are available in the full profile.
Complete people profiles for Biolog
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biolog
Biolog has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Anaerobesystems, MIDI Labs and Microbial Identification.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Anaerobic chambers and pre-reduced culture media are manufactured. | anaerobesystems.com | 0 | Feb 2025 | •••• | ||
Microbial testing and identification services are offered by MIDI Labs. | midilabs.com | Newark, United States | 1996 | Jan 2023 | •••• | |
Chemical data analysis and microbial identification solutions are offered. | midi-inc.com | Newark, United States | 1991 | Jan 2023 | •••• |
Complete acquisition details for Biolog
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Biolog
6 dated milestones of Biolog across 41 years, from founding to its latest funding, stage changes and deals.
- Founded Biolog is founded.
- Funding First funding round of $1.4M.
- Acquisition Acquires MIDI Labs.
- Acquisition Acquires Microbial Identification.
- Funding Latest funding round, Series A, of $16.1M.
- Acquisition Acquires Anaerobesystems.
Competitors of Biolog
Biolog has 3 listed competitors in our database, 3 of them funded. They include 10X Genomics, Mission Bio and Cellares.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 10xgenomics.com | 2012 | Pleasanton, United States | $199.9M | 961 | Instrument systems for genomic research and sequencing libraries are developed. | |
| missionbio.com | 2014 | San Francisco, United States | $110M | 109 | Single-cell multi-omics platform is provided for genotypic and phenotypic analysis. | |
| cellares.com | 2019 | San Francisco, United States | $355M | Medical devices for cell-based therapy manufacturing are produced. |
Detailed competitors of Biolog
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Biolog
The website of Biolog (biolog.com) receives about 12.4K visits a month.
- Monthly visits12.4K
▼ 11% vs previous month
Websites whose visitors overlap most with Biolog. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| midi-inc.com | 100% | View details | |||
iul-inst.com | iul-inst.com | 95% | – | ||
| neogen.com | 91% | 177.9K | #243,259 | View details | |
| bio-rad.com | 85% | 665.2K | #79,666 | View details | |
| appliedbiosystems.com | 82% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Biolog
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Biolog (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biolog
Complete news archive for Biolog
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biolog
Biolog was founded in 1984 and raised its 1st funding round 23 years after it was founded.
Biolog is headquartered in Hayward, United States. It is registered at Hayward, California, United States.
Biolog is a funded company, having raised a total of $33.62M across 6 funding rounds to date. The company's 1st funding round was a Grant of $1.4M, raised on Sep 2007.
Biolog has 27 employees.
Founded in 1984 and headquartered in Hayward, United States, Biolog focuses on biotechnology solutions for microbial identification and analysis. Technologies such as the Microbial ID System are utilized to identify over 2,900 species of aerobic and anaerobic bacteria, yeasts, and fungi. Chromogenic media like Rainbow Agar, EcoPlates for community profiling, and Phenotype MicroArrays for parallel phenotype assessment are offered. Research services based on Phenotype MicroArrays are also conducted.
Biolog's top competitors include 10X Genomics, Mission Bio and Cellares.
Biolog offers Odin ID Station, EcoPlate, Anaerobic Chambers, and GEN III Test Panel.
Biolog has made 3 acquisitions, including Anaerobesystems, MIDI Labs, and Microbial Identification.
Biolog has 4 investors. Key investors include HHS, Broadoak Capital Partners, Research Corporation Technologies, and Redfund Capital.
Biolog operates through Biolog, Inc..